# Study of STX-100 in Renal Transplant Patients With Interstitial Fibrosis and Tubular Atrophy (IF/TA)

> **NCT00878761** · PHASE2 · WITHDRAWN · sponsor: **Stromedix, Inc.** · enrollment: 48 (estimated)

## Conditions studied

- Chronic Allograft Dysfunction

## Interventions

- **BIOLOGICAL:** STX-100

## Key facts

- **NCT ID:** NCT00878761
- **Lead sponsor:** Stromedix, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-09
- **Primary completion:** 2011-10
- **Final completion:** 2011-12
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2011-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00878761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00878761, "Study of STX-100 in Renal Transplant Patients With Interstitial Fibrosis and Tubular Atrophy (IF/TA)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00878761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*